After kicking off 2024 with the news that it had begun restructuring its manufacturing footprint, and following last summer’s sell-off of two product portfolios, AngioDynamics is putting more of its ...

COLONIE — Latham's AngioDynamics is alleging that a major competitor in the medical device market, C.R. Bard, is violating anti-trust laws in the sale of its catheters. In a lawsuit filed in U.S.

AngioDynamics has announced it has received FDA clearance for a new peripherally inserted central catheter, according to a news release. The company’s BioFlo peripherally inserted central catheters ...

AngioDynamics, Inc. ANGO recently announced the US Food and Drug Administration (FDA) clearance for the Auryon XL Catheter, a 225-cm radial access catheter, for use with the Auryon Atherectomy System ...

Acquisitions broaden Merit’s therapeutic platform with diverse dialysis product solutions and expand its access catheter offering Acquisitions projected to add approximately $30 million of revenue, on ...

AngioDynamics has completed a strategic transformation, divesting non-core assets and focusing on high-growth MedTech platforms, driving accelerating revenue and margin improvement. Recent results ...